Investigation of the reaction of myosmine with sodium nitrite in vitro and in rats.

Previous studies have shown that the minor tobacco alkaloid myosmine (5) reacts with NaNO2 in the presence of acid to yield 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB, 8) via 4-(3-pyridyl)-4-oxobutanediazohydroxide (7). Intermediate 7 is also formed in the metabolism of the tobacco-specific nitrosamines N'-nitrosonornicotine (NNN, 1) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK, 2), resulting in pyridyloxobutylation of DNA and Hb. These pyridyloxobutyl adducts can be quantified by analyzing HPB released upon acid treatment of DNA or base treatment of Hb. Quantitation of HPB-releasing DNA and Hb adducts has been used to assess the metabolic activation of NNN and NNK in smokers and smokeless tobacco users. Because myosmine is found in the diet as well as in tobacco products, it has been suggested that nitrosation of myosmine could lead to the formation of HPB-releasing adducts in people not exposed to tobacco products. We investigated the nitrosation of myosmine in vitro and in vivo in rats. The reaction of myosmine with NaNO2 under acidic conditions produced HPB, as previously reported. A new product was identified as 3'-oximinomyosmine (11) based on its spectral properties. NNN was not detected. Groups of rats were treated with NNN, NNK, myosmine, NaNO2, or combinations of myosmine and NaNO2. HPB-releasing Hb and DNA adducts were clearly detected in the rats treated with NNN or NNK, but we found no evidence for production of these adducts from the combination of myosmine plus NaNO2. The results of this study do not support the hypothesis that exposure to dietary myosmine could lead to HPB-releasing DNA or Hb adducts in humans.

[1]  E. Richter,et al.  Genotoxic effects of myosmine in a human esophageal adenocarcinoma cell line. , 2006, Toxicology.

[2]  S. Hecht,et al.  Identification of an acetaldehyde adduct in human liver DNA and quantitation as N2-ethyldeoxyguanosine. , 2006, Chemical research in toxicology.

[3]  W. Zwickenpflug,et al.  Reaction of the tobacco alkaloid myosmine with hydrogen peroxide. , 2006, Chemical research in toxicology.

[4]  E. Richter,et al.  METABOLISM OF MYOSMINE IN WISTAR RATS , 2005, Drug Metabolism and Disposition.

[5]  S. Hecht,et al.  Tobacco-Specific Nitrosamines and Their Pyridine-N-glucuronides in the Urine of Smokers and Smokeless Tobacco Users , 2005, Cancer Epidemiology Biomarkers & Prevention.

[6]  S. Hecht,et al.  Cytochrome P450 enzymes as catalysts of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco specific carcinogen. , 2005, Chemical research in toxicology.

[7]  S. Hecht,et al.  Identification of O2-substituted pyrimidine adducts formed in reactions of 4-(acetoxymethylnitrosamino)- 1-(3-pyridyl)-1-butanone and 4-(acetoxymethylnitros- amino)-1-(3-pyridyl)-1-butanol with DNA. , 2004, Chemical research in toxicology.

[8]  E. Richter,et al.  Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines , 1994, The clinical investigator.

[9]  E. Richter,et al.  Genotoxic effects of myosmine in human lymphocytes and upper aerodigestive tract epithelial cells. , 2003, Toxicology.

[10]  Stephen S. Hecht,et al.  Tobacco carcinogens, their biomarkers and tobacco-induced cancer , 2003, Nature Reviews Cancer.

[11]  Shana J Sturla,et al.  Identification of adducts formed by pyridyloxobutylation of deoxyguanosine and DNA by 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone, a chemically activated form of tobacco specific carcinogens. , 2003, Chemical research in toxicology.

[12]  S. Hecht,et al.  Effects of benzyl isothiocyanate and 2-phenethyl isothiocyanate on benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism in F-344 rats. , 2003, Carcinogenesis.

[13]  E. Richter,et al.  Nitrosation of dietary myosmine as risk factor of human cancer. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[14]  E. Richter,et al.  New sources of dietary myosmine uptake from cereals, fruits, vegetables, and milk. , 2002, Journal of agricultural and food chemistry.

[15]  S. Hecht,et al.  Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. , 2002, Carcinogenesis.

[16]  W. Zwickenpflug.  N-Nitrosation of myosmine yields HPB (4-hydroxy-1-(3-pyridyl)-1-butanone) and NNN (N-nitrosonornicotine). , 2000, Journal of agricultural and food chemistry.

[17]  W. Ahrens,et al.  4-Hydroxy-1-(3-pyridyl)-1-butanone-hemoglobin adducts as biomarkers of exposure to tobacco smoke: validation of a method to be used in multicenter studies. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  E. Richter,et al.  Occurrence of the Tobacco Alkaloid Myosmine in Nuts and Nut Products of Arachus hypogaea and Corylus avellana , 1998 .

[19]  S. Hecht,et al.  Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. , 1998, Chemical research in toxicology.

[20]  C. Kutzer,et al.  Haemoglobin adducts from aromatic amines and tobacco specific nitrosamines in pregnant smoking and non smoking women. , 1998, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[21]  S. Murphy,et al.  Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[22]  S. Hecht,et al.  Tobacco-specific nitrosamine-hemoglobin adducts. , 1994, Methods in enzymology.

[23]  S. Hecht,et al.  Evidence that a hemoglobin adduct of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a 4-(3-pyridyl)-4-oxobutyl carboxylic acid ester. , 1992, Chemical research in toxicology.

[24]  J. Resau,et al.  Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. , 1991, Chemical research in toxicology.

[25]  S. Hecht,et al.  Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff dippers, smokers, and nonsmokers. , 1990, Cancer research.

[26]  S. Hecht,et al.  Investigations of metabolic precursors to hemoglobin and DNA adducts of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 1990, Carcinogenesis.

[27]  D Hoffmann,et al.  The relevance of tobacco-specific nitrosamines to human cancer. , 1989, Cancer surveys.

[28]  S. Hecht,et al.  Formation of hemoglobin adducts upon treatment of F344 rats with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine. , 1987, Cancer research.

[29]  S. Hecht,et al.  Effects of alpha-deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. , 1987, Carcinogenesis.

[30]  D. Hoffmann,et al.  Nitrogen-containing compounds in tobacco and tobacco smoke. , 1977 .

[31]  S. Hecht,et al.  Chemical Studies on Tobacco Smoke: LI: Studies on Non-Volatile Nitrosamines in Tobacco , 1977 .

[32]  R. Moss.  SOME CHEMISTRY OF ALKANEDIAZOTATES , 1975 .

[33]  D. Hoffmann,et al.  Chemical studies on tobacco smoke XXIII. Synthesis of carbon‐14 labelled myosmine, nornicotine and N′‐nitrosonornicotine , 1974 .

[34]  Paul G. Haines,et al.  Chemical Reactivity of Myosmine , 1945 .